P2.17-25 Genomic Insight into Stage I Pulmonary Adenocarcinoma for Recurrence by Targeted Next-Generation Sequencing Analysis
Abstract
Despite surgical resection, stage I pulmonary adenocarcinoma has a recurrence rate of 18.4%–25%. Prognostic markers of localized lung adenocarcinoma remain undefined. Targeted next-generation sequencing (NGS) is supposed to be useful to identify recurrence-related genes. We aimed to identify genes and co-occurring mutations that might predict recurrence after surgical resection of stage I pulmonary adenocarcinoma through targeted NGS. Tissues...
Paper Details
Title
P2.17-25 Genomic Insight into Stage I Pulmonary Adenocarcinoma for Recurrence by Targeted Next-Generation Sequencing Analysis
Published Date
Oct 1, 2019
Journal
Volume
14
Issue
10
Pages
S894 - S894
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History